This is the authors' abstract. We don't add key points for this paper.
This unit (1) provides background into understanding how agents that target specific molecules or receptors (molecular-targeted agents), in particular, agents affecting the tumor vasculature (perivasculature network in tumors), interact with and modify radiation therapy; (2) details factors affecting interpretation of results in murine tumor model experiments utilizing radiation therapy and drug combinations; and (3) provides specific protocols for the application of radiation therapy, both alone and in combination with chemotherapy and/or molecular-targeted agents.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Burd et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: